Zobrazeno 1 - 10
of 10 107
pro vyhledávání: '"Hypoxic–ischemic encephalopathy"'
Publikováno v:
Laboratory Animal Research, Vol 40, Iss 1, Pp 1-12 (2024)
Abstract We systematically reviewed the evidence from animal studies assessing the effects of pentoxifylline on neonatal hypoxic-ischemic encephalopathy (HIE). The PubMed, EMBASE, EMCARE, MEDLINE, Cochrane Library, and Google Scholar databases were s
Externí odkaz:
https://doaj.org/article/032c40c92f6f4bc8a4f07f8780cfae39
Autor:
L. V. Puzyreva, V. I. Larkin, V. V. Mishkin, S. G. Pimov, I. I. Larkin, E. P. Schaefer, L. N. Paimanovа, E. A. Gashina, E. F. Lobova, N. A. Sabaeva
Publikováno v:
Детские инфекции (Москва), Vol 23, Iss 4, Pp 57-62 (2024)
Whooping cough is a widespread infectious disease, the manifestations of which vary from nonspecific cough to life-threatening conditions with the development of apnea, hypoxic damage to the central nervous system, and respiratory failure, especially
Externí odkaz:
https://doaj.org/article/ddb417bfc35d42988828fd9f45345964
Autor:
Mengnan Wu, Yuan Xu, Xiaoli Ji, Yingying Zhou, Yuan Li, Ban Feng, Qian Cheng, Hui He, Xingsheng Peng, Wenhao Zhou, Yuejun Chen, Man Xiong
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Background Hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal disability and mortality. Although intensive studies and therapeutic approaches, there are limited restorative treatments till now. Human embryonic stem cell (hESC
Externí odkaz:
https://doaj.org/article/c9eac44a0d794523896ed8db015958d7
Autor:
T.K. Mavropulo, M.V. Solomenko
Publikováno v:
Zdorovʹe Rebenka, Vol 19, Iss 5, Pp 304-311 (2024)
Background. Currently, therapeutic hypothermia (TH) is the only approved method for treating hypoxic-ischemic encephalopathy (HIE) that helps improve outcomes. However, it also has significant drawbacks, including the necessity for expensive equipmen
Externí odkaz:
https://doaj.org/article/de056e118f55413db706c95fa0799080
Publikováno v:
Italian Journal of Pediatrics, Vol 50, Iss 1, Pp 1-10 (2024)
Abstract Background Neonatal hypoxic ischemic encephalopathy (HIE) leads to different degrees of neurological sequelae. The incidence of HIE is relatively high, and the causal pathways leading to HIE are still controversial. This study aimed to inves
Externí odkaz:
https://doaj.org/article/52d2b213cb044470a0d71bd35079af4a
Autor:
Subham Puhan, Saugata Chaudhuri
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 8, Pp 127-130 (2024)
Background: The mortality rate is approximately 20% and the frequency of neurodevelopmental sequelae in surviving newborns is approximately 30% in perinatal asphyxia; hypoxic-ischemic encephalopathy (HIE) is brain dysfunction due to lack of oxygen an
Externí odkaz:
https://doaj.org/article/df6e32e7c047487e81bd383a22c4a40a
Publikováno v:
中西医结合护理, Vol 10, Iss 7, Pp 45-48 (2024)
Objective To investigate the effect of holistic nursing interventions in newborns with hypoxic-ischemic encephalopathy. Methods Totally 60 newborns with hypoxic-ischemic encephalopathy were recruited as research objects. Based on the basic treatment
Externí odkaz:
https://doaj.org/article/e4443b931dd94be694fc5de09cb4c4f1
Publikováno v:
Nigerian Journal of Paediatrics, Vol 45, Iss 2, Pp 86-90 (2024)
Background: Vasoactive drugs such as low dosage dopamine are often used in the intensive care of asphyxiated term neonates but there is insufficient evidence to support the practice. Aims: To evaluate the impact of low dose dopamine on the clinica
Externí odkaz:
https://doaj.org/article/a497181a12f34147b9d473bfafd3d1e2
Publikováno v:
Pediatrics and Neonatology, Vol 65, Iss 4, Pp 354-358 (2024)
Objective: We aimed to develop a risk scoring system as a predictor of 24-month neurodevelopmental outcomes (cognitive, language, and motor) for neonates treated with therapeutic hypothermia for hypoxic-ischemic encephalopathy (HIE). Methods: This wa
Externí odkaz:
https://doaj.org/article/7a2bd0615fea431d807ec6025709c61c
Autor:
Elias Jabbour, MSc, Pia Wintermark, MD, PhD, Wijdan Basfar, MD, Sharina Patel, MD, MSc, Petros Pechlivanoglou, PhD, Prakesh Shah, MD, MSc, Marc Beltempo, MD, MSc, Prakesh S. Shah, MD, MSc, Marc Beltempo, MD, Jaideep Kanungo, MD, Joseph Ting, MD, Zenon Cieslak, MD, Rebecca Sherlock, MD, Ayman Abou Mehrem, MD, Jennifer Toye, MD, Khalid Aziz, MBBS, Carlos Fajardo, MD, Jaya Bodani, MD, Lannae Strueby, MD, Mary Seshia, MBChB, Deepak Louis, MD, Ruben Alvaro, MD, Amit Mukerji, MD, Orlando Da Silva, MD, MSc, Sajit Augustine, MD, Kyong-Soon Lee, MD, MSc, Eugene Ng, MD, Brigitte Lemyre, MD, Thierry Daboval, MD, Faiza Khurshid, MD, Victoria Bizgu, MD, Keith Barrington, MBChB, Anie Lapointe, MD, Guillaume Ethier, NNP, Christine Drolet, MD, Bruno Piedboeuf, MD, Martine Claveau, MSc, LLM, NNP, Marie St-Hilaire, MD, Valerie Bertelle, MD, Edith Masse, MD, Roderick Canning, MD, Hala Makary, MD, Cecil Ojah, MBBS, Luis Monterrosa, MD, Julie Emberley, MD, Jehier Afifi, MB, BCh, MSc, Andrzej Kajetanowicz, MD, Shoo K. Lee, MBBS, PhD
Publikováno v:
Journal of Pediatrics: Clinical Practice, Vol 14, Iss , Pp 200124- (2024)
Objective: Therapeutic hypothermia (TH) is the standard treatment for neonates with hypoxic-ischemic encephalopathy (HIE). Validated cost estimates are required to better evaluate the cost-effectiveness of additional interventions during TH. The goal
Externí odkaz:
https://doaj.org/article/1d9ebb9ae56348cf9d850f24af38348d